For example, AQP4-immunoreactivity is increased in AD [47] and its mis-localisation is related to the formation of β-amyloid plaques [49], and reduced AQP4 expression has been reported in psychiatric and demyelinating disorders [5]. This evidence concerns the gene AQP4 and Alzheimer disease.